| Stanley A Wade Jr, MD | |
|
1800 12th St, Meridian, MS 39301-4158 | |
| (601) 703-9223 | |
| (601) 703-9405 |
| Full Name | Stanley A Wade Jr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 55 Years |
| Location | 1800 12th St, Meridian, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578545984 | NPI | - | NPPES |
| 00115344 | Medicaid | MS | |
| 730-12551 | Other | BLUE CROSS OF AL | |
| P00069795 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 06967 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush Foundation Hospital | Meridian, MS | Hospital |
| Choctaw General Hospital | Butler, AL | Hospital |
| Anderson Regional Medical Ctr | Meridian, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Foundation Inc | 9234043712 | 125 |
News Archive
A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis.
The 60th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) - the largest of its kind in the world - will bring together in one place global experts who are battling a wide range of bacteria, viruses, parasites and other pathogens that each year kill or sicken hundreds of millions of people.
Pfizer Inc. today announced that data from a Phase 2 efficacy and safety study of tasocitinib the company's investigational oral JAK inhibitor, met its primary endpoint of a statistically significant greater proportion of patients achieving at least a 75 percent reduction from baseline in PASI (Psoriasis Area and Severity Index) at week 12 in individuals with chronic moderate to severe plaque psoriasis.
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
› Verified 7 days ago
| Entity Name | Medical Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609820539 PECOS PAC ID: 9234043712 Enrollment ID: O20031118000855 |
News Archive
A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis.
The 60th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) - the largest of its kind in the world - will bring together in one place global experts who are battling a wide range of bacteria, viruses, parasites and other pathogens that each year kill or sicken hundreds of millions of people.
Pfizer Inc. today announced that data from a Phase 2 efficacy and safety study of tasocitinib the company's investigational oral JAK inhibitor, met its primary endpoint of a statistically significant greater proportion of patients achieving at least a 75 percent reduction from baseline in PASI (Psoriasis Area and Severity Index) at week 12 in individuals with chronic moderate to severe plaque psoriasis.
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stanley A Wade Jr, MD 1800 12th St, Meridian, MS 39301-4158 Ph: (601) 703-4282 | Stanley A Wade Jr, MD 1800 12th St, Meridian, MS 39301-4158 Ph: (601) 703-9223 |
News Archive
A new technology that relies on a moth-infecting virus and nanomagnets could be used to edit defective genes that give rise to diseases like sickle cell, muscular dystrophy and cystic fibrosis.
The 60th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) - the largest of its kind in the world - will bring together in one place global experts who are battling a wide range of bacteria, viruses, parasites and other pathogens that each year kill or sicken hundreds of millions of people.
Pfizer Inc. today announced that data from a Phase 2 efficacy and safety study of tasocitinib the company's investigational oral JAK inhibitor, met its primary endpoint of a statistically significant greater proportion of patients achieving at least a 75 percent reduction from baseline in PASI (Psoriasis Area and Severity Index) at week 12 in individuals with chronic moderate to severe plaque psoriasis.
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
› Verified 7 days ago
Lewis Nolan Cunningham, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9224 Fax: 601-703-4973 | |
Robert E Dilworth, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1600 22nd Ave, Medical Towers 3, 3rd Fl, Meridian, MS 39301 Phone: 601-693-1055 Fax: 601-482-5312 | |
Richard M. Vise, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1800 12th St, Meridian, MS 39301 Phone: 601-703-9223 Fax: 601-703-9405 | |
Mark T Phillips, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1600 22nd Ave, Medical Towers Iii, 3rd Floor, Meridian, MS 39301 Phone: 601-693-1055 Fax: 601-482-5312 |